Litcius/Paper detail

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group

Nicolás Mendoza, Isabel Ramírez, Esther de la Viuda, Pluvio Coronado, Laura Baquedano, Plácido Llaneza, Verónica Balsera Nieto, Borja Otero, Sonia Sánchez, Visitación Álvarez de Frutos, Leire Andraca, Patricio Barriga, Zully Benítez, Teresa Bombas, Mª. Jesús Cancelo, Antonio Cano, Camil Castelo‐Branco, Marta Correa, José Luis Doval, María Fasero, Gabriel Fiol, Néstor César Garello, Andrea R. Genazzani, Ana Isabel Gómez Córdoba, Ma Ángeles Gómez, Silvia González‐Gómez, Dimitrios G. Goulis, Misericordia Guinot, Luis Rolando Hernández, Sonia Herrero, Eva Iglesias, Ana Rosa Jurado, Iñaki Lete, Daniel Lubián, Milagros Martínez, A. Nieto, Laura Nieto, Santiago Palacios, Milagros Pedreira, Eduardo Pérez‐Campos, M.J. Plà, Jesús Presa, Francisco Quereda, Miriam Ribes, Pablo Romero, Beatriz Roca, Antonio Sánchez-Capilla, Rafael Sánchez‐Borrego, Ana Santaballa, Amparo Santamaría, Tommaso Simoncini, Francisco J. Tinahones, Joaquím Calaf

2022Maturitas44 citationsDOI

Topics & Concepts

MedicineHormone therapyHormone replacement therapy (female-to-male)Family medicineSystematic reviewMEDLINEMenopauseMedical literatureGynecologyBreast cancerCancerInternal medicinePathologyLawTestosterone (patch)Political scienceMenopause: Health Impacts and TreatmentsEstrogen and related hormone effectsCancer Risks and Factors